Cited 0 times in
Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이충근 | - |
dc.date.accessioned | 2023-06-02T01:09:40Z | - |
dc.date.available | 2023-06-02T01:09:40Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194694 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Do-Youn Oh | - |
dc.contributor.googleauthor | Jin Won Kim | - |
dc.contributor.googleauthor | Myung Ah Lee | - |
dc.contributor.googleauthor | Ilhwan Kim | - |
dc.contributor.googleauthor | Choong-kun Lee | - |
dc.contributor.googleauthor | Young Mi Seol | - |
dc.contributor.googleauthor | Changhoon Yoo | - |
dc.contributor.googleauthor | Sang Cheul Oh | - |
dc.contributor.googleauthor | Woo Kyun Bae | - |
dc.contributor.googleauthor | Hongjae Chon | - |
dc.contributor.googleauthor | In Sil Choi | - |
dc.contributor.googleauthor | Jeesun Yoon | - |
dc.contributor.googleauthor | Joon Oh Park | - |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.TPS621 | - |
dc.contributor.localId | A03259 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS621 | - |
dc.contributor.alternativeName | Lee, Choong-kun | - |
dc.contributor.affiliatedAuthor | 이충근 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 4 suppl | - |
dc.citation.startPage | TPS621 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS621, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.